93 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34392748 | The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review. | 2022 Feb | 1 |
2 | 35163991 | Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. | 2022 Jan 22 | 1 |
3 | 35203674 | Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model. | 2022 Feb 16 | 1 |
4 | 35364117 | A novel therapeutic combination of sitagliptin and melatonin regenerates pancreatic β-cells in mouse and human islets. | 2022 Aug | 2 |
5 | 35620578 | Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota Disorder. | 2022 | 2 |
6 | 33148870 | Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 Cells. | 2021 Mar 1 | 6 |
7 | 33258801 | Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis. | 2021 Feb | 2 |
8 | 33513866 | DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model. | 2021 Jan 27 | 2 |
9 | 33735157 | Functional Dissection of CD26 and Its Pharmacological Inhibition by Sitagliptin During Skin Wound Healing. | 2021 Mar 18 | 4 |
10 | 33781961 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice. | 2021 Oct | 3 |
11 | 33975617 | The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy. | 2021 May 11 | 2 |
12 | 34493714 | Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. | 2021 Sep 7 | 7 |
13 | 34497344 | Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice. | 2021 Sep 8 | 2 |
14 | 34631556 | Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS-NF-кB-NLRP3 Axis. | 2021 | 1 |
15 | 34944588 | Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy. | 2021 Nov 26 | 2 |
16 | 31350829 | Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis. | 2020 Jan | 1 |
17 | 32281218 | Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway. | 2020 Jun | 2 |
18 | 32398684 | Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. | 2020 Nov | 2 |
19 | 32430013 | Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. | 2020 May 19 | 1 |
20 | 32724076 | Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. | 2020 Jul 28 | 1 |
21 | 32774687 | Sitagliptin Mitigates Total Body Irradiation-Induced Hematopoietic Injury in Mice. | 2020 | 2 |
22 | 33126761 | Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects. | 2020 Oct 28 | 1 |
23 | 33182020 | Long-term inhibition of dipeptidyl-peptidase 4 reduces islet infiltration and downregulates IL-1β and IL-12 in NOD mice. | 2020 Nov | 2 |
24 | 30520247 | Combined effect of GABA and glucagon-like peptide-1 receptor agonist on cytokine-induced apoptosis in pancreatic β-cell line and isolated human islets. | 2019 Jul | 1 |
25 | 30696428 | Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes. | 2019 Jan 29 | 1 |
26 | 30707388 | DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes. | 2019 Apr | 1 |
27 | 30778250 | Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth. | 2019 Mar | 1 |
28 | 30940309 | The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice via inhibiting the TGF-β/Smad signal pathway. | 2019 Apr 1 | 2 |
29 | 31077717 | Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice. | 2019 Jul 1 | 2 |
30 | 31474716 | Diurnal Variation of Sitagliptin-Induced Pharmacological Effects in C57BL/6J Mice. | 2019 | 1 |
31 | 31827684 | DPP4 Inhibitor Attenuates Severe Acute Pancreatitis-Associated Intestinal Inflammation via Nrf2 Signaling. | 2019 | 1 |
32 | 28799229 | Sitagliptin-mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes. | 2018 Jan | 2 |
33 | 29136947 | The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice. | 2018 Jan | 1 |
34 | 29203510 | Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery. | 2018 Feb | 1 |
35 | 29531541 | Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling. | 2018 | 1 |
36 | 30028901 | A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity. | 2018 Oct | 2 |
37 | 30116740 | DPP-4 Inhibitor Sitagliptin Improves Cardiac Function and Glucose Homeostasis and Ameliorates β-Cell Dysfunction Together with Reducing S6K1 Activation and IRS-1 and IRS-2 Degradation in Obesity Female Mice. | 2018 | 2 |
38 | 30123267 | Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice. | 2018 | 2 |
39 | 30186862 | Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease. | 2018 | 1 |
40 | 30188745 | DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice. | 2018 Nov 1 | 4 |
41 | 30202822 | Dipeptidyl Peptidase-4 Is a Pro-Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells. | 2018 Sep | 2 |
42 | 30343953 | Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents. | 2018 Dec 15 | 1 |
43 | 28322746 | Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. | 2017 May 15 | 2 |
44 | 28334048 | Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity. | 2017 | 1 |
45 | 28355570 | Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis. | 2017 Mar 28 | 1 |
46 | 28442582 | LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice. | 2017 Jul | 1 |
47 | 28676760 | Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice. | 2017 | 1 |
48 | 28703769 | Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling. | 2017 Jul 13 | 1 |
49 | 28713268 | Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro. | 2017 | 2 |
50 | 28943949 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, suppresses CXCL5 and SDF-1 and does not accelerate intestinal neoplasia formation in ApcMin/+ mice fed a high-fat diet. | 2017 Oct | 1 |